Integral Molecular is a research-driven biotechnology company creating innovative technologies and therapeutic antibodies for under-exploited membrane protein targets, including GPCRs, ion channels, transporters, and viral envelopes.

15+ years experience optimizing membrane proteins

Work with Top 10 pharmaceutical companies

300+ customers and partners

Upcoming Events

Expanded SARS-CoV-2 RVP Variant Offerings
April 21 | Webinar

BIO International 
June 14-17 | Virtual

 PEGS Europe
November 2-4 | Virtual